ASFX: AI 评分 50/100 — AI 分析 (4月 2026)

American Scientific Resources, Incorporated is in liquidation. The company formerly developed, manufactured, and distributed medical products and devices for children and adults, including thermometers, nebulizers, and other healthcare-related items.

Key Facts: AI Score: 50/100 Sector: Healthcare

公司概况

概要：

American Scientific Resources, Incorporated, currently in liquidation, formerly operated in the medical instruments and supplies sector, focusing on developing and distributing products for both children and adults. Its product line included thermometers, respiratory devices, and other healthcare aids, primarily distributed through retail channels and online platforms. The company was based in Weston, Florida.

ASFX是做什么的？

American Scientific Resources, Incorporated was a developer, manufacturer, and distributor of medical products and devices aimed at both children and adults. Founded with the mission of providing innovative healthcare solutions, the company offered a diverse portfolio of products designed to address various needs within the healthcare market. Its product lineup included the Thermofocus 5-in-1 non-contact clinical thermometer, VeraTemp and VeraTemp+ non-contact thermometers, and the Scald Safe Water temperature disc, designed to prevent scalding in baby baths. Additionally, the company offered WhistleWatch, a flow monitoring device for children with respiratory issues, and the Kidz-Med portable ultrasonic nebulizer for treating conditions like asthma and bronchitis. Further expanding its product range, American Scientific Resources provided the Kidz-Med Medicine Dispenser, the Kidz-Med Mommy Recorder, Bip DVDs, the Mebby product line (including breast pumps and baby bottles), and Wee Target. The company also offered the Disintegrator, a home needle and lancet destruction device. Distribution was primarily achieved through retail drug and grocery chains, medical suppliers, its own website, and other online platforms. However, on February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against the company, and the petition was approved on March 28, 2012. As of 2026, American Scientific Resources, Inc. is in liquidation.

ASFX的投资论点是什么？

American Scientific Resources, Incorporated presents a complex investment case due to its current liquidation status. The company's past focus on developing and distributing medical devices for children and adults suggests a potential market opportunity, but its financial instability and subsequent liquidation significantly undermine any investment appeal. The company's negative free cash flow of $-0.00B and a market capitalization of $0.00B further highlight its distressed state. While its products once addressed specific needs in the healthcare market, the liquidation process raises substantial concerns about asset recovery and potential returns for investors. The company's beta of -3.31 may indicate low volatility, but this is largely irrelevant given its liquidation status.

ASFX在哪个行业运营？

American Scientific Resources, Incorporated operated within the medical instruments and supplies industry, a sector characterized by continuous innovation and stringent regulatory oversight. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements in medical devices. Competitors in this space, such as CEVE, HCANF, HSMD, LOWLF, and MDIT, operate in a dynamic environment where product differentiation and regulatory compliance are critical for success. However, given American Scientific Resources' liquidation status, it no longer actively participates in or influences the competitive landscape.

Medical - Instruments & Supplies

Healthcare

ASFX有哪些增长机遇？

N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.

Market Cap of $0.00B reflects the company's liquidation status and lack of active trading.
Gross Margin of 21.5% indicates the profitability of products before liquidation, but is not indicative of current financial health.
Free Cash Flow of $-0.00B highlights the company's financial struggles leading to liquidation.
Beta of -3.31 suggests a low correlation with the market, but is not a relevant metric given the company's current state.
Liquidation status indicates significant financial distress and potential loss of investment.

ASFX提供哪些产品和服务？

Developed and manufactured medical products for children and adults.
Offered non-contact clinical thermometers.
Provided respiratory monitoring devices.
Developed devices for safe baby care, such as bath water temperature discs.
Distributed products through retail drug and grocery chains.
Sold products through its website and online platforms.

ASFX如何赚钱？

Developed and manufactured medical devices.
Distributed products through retail and online channels.
Generated revenue through product sales.

Parents and caregivers of infants and children.
Adults requiring medical devices for personal health monitoring.
Retail drug and grocery chains.
Medical suppliers.

N/A: Given the company's liquidation status, it no longer possesses a sustainable competitive advantage or 'moat'.

什么因素可能推动ASFX股价上涨？

N/A: The company is in liquidation.

ASFX的主要风险是什么？

Ongoing: Liquidation process may result in complete loss of investment.
Ongoing: Lack of financial transparency due to OTC Other status.
Ongoing: Minimal trading volume and liquidity.

ASFX的核心优势是什么？

N/A: Given the company's liquidation status, it no longer possesses any strengths.

ASFX的劣势是什么？

Liquidation status
Financial instability
Lack of ongoing operations

ASFX有哪些机遇？

N/A: Given the company's liquidation status, it has no opportunities.

ASFX面临哪些威胁？

N/A: Given the company's liquidation status, it faces no threats.

ASFX的竞争对手是谁？

Cerevel Therapeutics Holdings, Inc. — Focuses on developing therapies for neurological diseases. — (CEVE)
Healthcare AI Acquisition Corp. — Specializes in healthcare-related acquisitions. — (HCANF)
HSM Acquisition Corp. — Acquisition company focused on healthcare. — (HSMD)
Lowell Farms Inc. — Operates in the cannabis industry. — (LOWLF)
Medigus Ltd. — Develops minimally invasive surgical tools. — (MDIT)

Key Metrics

MoonshotScore: 50/100

Company Profile

Headquarters: Weston, US
Employees: 5
Founded: 1997

AI Insight

AI analysis pending for ASFX

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does American Scientific Resources, Incorporated do?

American Scientific Resources, Incorporated developed, manufactured, and distributed medical products and devices for children and adults. Its product line included non-contact thermometers, respiratory monitoring devices, and other healthcare-related items. The company primarily distributed its products through retail drug and grocery chains, medical suppliers, and online platforms. However, the company is currently in liquidation, and is no longer operating.

What do analysts say about ASFX stock?

Given American Scientific Resources, Incorporated's liquidation status, there is no current analyst coverage or consensus. The company's financial metrics, such as its market capitalization of $0.00B and negative free cash flow, reflect its distressed state. Any historical analyst ratings or price targets are no longer relevant due to the company's liquidation. Investors should focus on the liquidation process and potential asset recovery, if any.

What are the main risks for ASFX?

The primary risk for American Scientific Resources, Incorporated is its liquidation status, which could result in a complete loss of investment. As an OTC Other stock, it faces limited financial disclosure and regulatory oversight, increasing the potential for fraud or manipulation. Low liquidity and wide bid-ask spreads further exacerbate the risks. Investors should exercise extreme caution and conduct thorough due diligence before considering any investment in ASFX.